CD4 and neoplasm: Most animals of the combined αPD-1/α4-1BB ICI group demonstrated a stable or increased tumor core/margin ratio at the later imaging time point, suggesting that α4-1BB therapy increased the influx of CD4+ T cells into the TME (Fig. 5F).